Recombinant FOLR1 (Mirvetuximab Biosimilar) 抗体
Quick Overview for Recombinant FOLR1 (Mirvetuximab Biosimilar) 抗体 (ABIN7795120)
抗原
抗体类型
适用
宿主
克隆类型
标记
应用范围
质量等级
-
-
Expression System
- Mammalian cells
-
原理
- Mirvetuximab Biosimilar, Human FOLR1 Monoclonal Antibody
-
产品特性
- What is Mirvetuximab biosimilar research grade? Mirvetuximab biosimilar uses the same protein sequences as the therapeutic antibody Mirvetuximab. Mirvetuximab soravtansine is used as a treatment for epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. Mirvetuximab soravtansine is a folate receptor alpha (FRa)-directed antibody and microtubule inhibitor conjugate.
-
纯化方法
- Protein A or G affinity column
-
纯度
- >95 % by reducing SDS-PAGE
-
内毒素水平
- < 1 EU per 1 mg of the protein by the LAL method
-
免疫原
- Human FOLR1
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- > 3 mg/mL
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
-
-
- FOLR1 (Mirvetuximab Biosimilar)
-
别名
- Mirvetuximab Biosimilar
-
物质类
- Biosimilar
抗原
-